(Q54021581)

23 May 2018

title

Mechanisms for HIV-1 Entry: Current Strategies to Interfere with This Step. (English)

1 reference

23 May 2018

1

Georgia D. Tomaras

1 reference

23 May 2018

author name string

Michael L. Greenberg

series ordinal

2

1 reference

23 May 2018

publication date

1 February 2001

1 reference

23 May 2018

Current infectious disease reports

published in

1 reference

23 May 2018

volume

3

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

93-99

1 reference

23 May 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-001-0064-X

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-001-0064-X

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

12 December 2020

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

12 December 2020

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

12 December 2020

Inhibition of soluble CD4 therapy by antibodies to HIV.

1 reference

12 December 2020

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

12 December 2020

Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements

1 reference

12 December 2020

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

12 December 2020

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

12 December 2020

Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.

1 reference

12 December 2020

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

12 December 2020

Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission

1 reference

12 December 2020

Atomic structure of a thermostable subdomain of HIV-1 gp41

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

12 December 2020

Trimerization specificity in HIV-1 gp41: analysis with a GCN4 leucine zipper model

1 reference

12 December 2020

Antiviral effects of CD4 derivatives

1 reference

12 December 2020

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

12 December 2020

Correlations Between theIn VitroandIn VivoActivity of Anti-HIV Agents: Implications for Future Drug Deyelopment

1 reference

12 December 2020

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

12 December 2020

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

12 December 2020

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

12 December 2020

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

12 December 2020

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

12 December 2020

Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop

1 reference

12 December 2020

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

1 reference

12 December 2020

A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion

1 reference

12 December 2020

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

12 December 2020

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

12 December 2020

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

1 reference

12 December 2020

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

12 December 2020

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

1 reference

12 December 2020

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

12 December 2020

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

1 reference

12 December 2020

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

12 December 2020

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

12 December 2020

Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.

1 reference

12 December 2020

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

12 December 2020

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

12 December 2020

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

1 reference

12 December 2020

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

12 December 2020

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

10.1007/S11908-001-0064-X

Identifiers

DOI

1 reference

23 May 2018

release_xznzer33e5d4zl5dd23nzgvqke

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xznzer33e5d4zl5dd23nzgvqke

24 November 2022

mapped directly with Wikidata item

1 reference

23 May 2018